Product Images Roflumilast

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Roflumilast NDC 59651-275 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure1 - roflumilast fig1

Figure1 - roflumilast fig1

This appears to be a table of drug interactions or effects, indicating changes in maximum concentration (Cmax) and area under the curve (AUC) due to different medications. It also includes recommendations for adjusting doses or using caution when combining certain drugs. However, the specific drugs and their interactions are not legible due to errors.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mcg (30 Tablet Bottle) - roflumilast fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mcg (30 Tablet Bottle) - roflumilast fig2

Each tablet of Roflumilast contains 500 mega grams and is distributed by Aurobindo Pharma USA, Inc. The recommended dose for adults is one tablet a day, see package insert for further information. The tablets are made in India and for pharmacy dispensing, the medication guide should be provided separately to each patient. Store the tablets at a controlled room temperature of 20°C to 25°C. The printed document contains dotted lines that should not be printed.*

Chemical Structure - roflumilast str

Chemical Structure - roflumilast str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.